Efficacy Comparison of Two Cholinolytics,Scopolamine and Azaprophen,When Used in Conjunction with Physostigmine and Pyridostigmine for Protection Against Organophosphate Exposure

Abstract

Pretreatment with either pyridostigmine (PYR) or physostigmine (PHY) followed by atropineoxime therapy is very effective in reducing the lethality of organophosphorus nerve agents. The therapeutic efficacy of scopolamine (SCP) versus azaprophen (AZA), when used in conjunction with PHY and PYR (PHY/PYR) combination pretreatment, was evaluated in guinea pigs challenged with 2 half-lethal doses of soman. Maximum postsoman decrement of rotarod performance was measured. Response surface methodology was employed to describe the relationship between the decrement and the PHY/PYR dosages. Results show that AZA is a more effective pretreatment adjunct at the behavioral deficit-free doses tested, AZA or SCP is as effective with PHY alone as with a PHY/PYR combination. Thus, PYR adds essentially nothing to the carbamate combination against soman-induced behavioral deficit.

References

1. Fleisher, J.H. and Harris, L.W. (1965). Dealkylation as a mechanism foraging of cholinesterase after poisoning with pinacolyl methylphosphonofluoridate. Biochem. Pharmacol. 14,641–650.

2. Berry, W.K. and Davies, D.R. (1970). The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2,-trimethylpropyl methylphosphonofluoridate. Biochem. Pharmacol. 19,927–934.

3. Lennox, W. J. , Harris, L.W. , Talbot, B.G. , and Anderson, D.R. (1985). Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality. Life Sci. 37, 793–798.

4. Leadbeater, L. , Inns, R.H. , and Rylands, J.M. (1985). Treatment of poisoning by soman. Fund. Appl. Toxicol. 5, S225–S231.

5. Harris, L. W. , Mcdonough, Jr. J.H. , Stitcher, D.L. and Lennox, W.J. (1984). Protection against both lethal and behavioral effects of soman. Drug Chem. Toxicol. 7, 605–642.

6. Beach, J. E. , Smallridge, R.C. , Chiang, P.K. , and Fein, H.G. (1988). Reversal of inhibition of prolactin secretion in cultured pituitary cells by muscarinic antagonists. J. Pharmacol. Exp. Ther. 246, 548–552.

7. Nakazato, Y. , Oleshansky, M.A. , and Chiang, P.K. (1988). Effects of muscarinic pharmacophores on the cholinergic regulation of catecholamine secretion from perfused adrenal glands. Arch. Int. Pharmacodyn. 293, 209–218.

8. Carroll, F. I. , Abraham, P. , Pharham, K. , Griffith, R.C. , Ahmad, A. , Richard, M.M. , Padilla, F.N. , Witkin, J.M. , and Chiang, P.K. (1987). 6-Methyl-6-azabicyclo[3.2.1]octan-3-ol 2,2-diphenylpropionate (Azaprophen), a highly potent antimuscarinic agent. J. Med. Chem. 30, 805–809.

9. Witkin, J. M. , Gordon, R.K. , and Chiang, P.K. (1987). Comparison of in vitro actions with behavioral effects of antimuscarinic agents. J. Pharmacol. Exp. Ther. 242, 796–803.

10.

10. Mays, M. Z. , Mcdonough, J.H. , Modrow, H. , Murrow, M. , Alvarez, R. , and Mccreesh, D. (1985). Performance on a one-way avoidance conditioning task following nerve agent intoxication. In: Proceedings Fifth Ann. Chem. Def. Biosci. Rev. Aberdeen Proving Ground, MD: U.S. Army Medical Research Institute of Chemical Defense. AD#B104126.

11.

11. Carter, W.H. Jr., Jones, D.E. , and Carchman, R.A. (1985). Application of response surface methods for evaluating the interactions of soman, atropine and pralidoxime chloride. Fund. Appl. Toxicol. 5, 232–241.

12.

12. Myers, R. M. (1986). Classical and modern regression with applications. Boston: PWS Publishers, Chap 9.

13.

13. Harris, L. W. , Stitcher, D.L. , and Heyl, W.C. (1980). The effects of pretreatments with carbamates, atropine and mecamylamine on survival and on soman-induced alterations in rat and rabbit brain acetylcholine. Life Sci. 26, 1885–1891.

14.

14. Harris, L. W. , Talbot, B.G. , Lennox, W.J. , Anderson, D.R. , and Solana, R.P. (1988). Physostigmine and adjunct pretreatment (alone and together with therapy) against nerve agent intoxication. Aberdeen Proving Ground, MD: U.S. Army Medical Research Institute of Chemical Defense. US AMRICD-TR-88–18.